True status of smear-positive pulmonary tuberculosis defaulters in Malawi

Bulletin of the World Health Organization

Volumn 77, Issue 5, 1999, Pages 386-391

  Kruyt, M L ^a   Kruyt, N D ^b   Boeree, M J ^c   Harries, A D ^d   Salaniponi, F M ^d   Van Noord, P A ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY OF MALAWI   (Malawi)

^d National Tuberculosis Programme   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE; HEALTH STATUS; TUBERCULOSIS;

ARTICLE; CONSULTATION; CONVALESCENCE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALAWI; MORTALITY; PATIENT COMPLIANCE; PATIENT TRANSPORT; SPUTUM SMEAR; TREATMENT OUTCOME;

AFRICA; AFRICA SOUTH OF THE SAHARA; CLINICAL RESEARCH; DEVELOPING COUNTRIES; DISEASES; EASTERN AFRICA; EDUCATION; ENGLISH SPEAKING AFRICA; HEALTH EDUCATION; INFECTIONS; MALAWI; RESEARCH METHODOLOGY; RESEARCH REPORT; TREATMENT; TUBERCULOSIS;

ADULT; COMMUNITY HEALTH CENTERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALAWI; MALE; MEDICAL RECORDS; PATIENT DROPOUTS; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

MALAWI;

EID: 0032997587     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Maher D et al. Treatment of tuberculosis: guidelines for national programmes, 2nd ed. Geneva, World Health Organization, 1997 (unpublished document WHO/TB/97.220 Rev. 1).
2. Enarson DA et al. Tuberculosis guide for low-income countries, 4th ed. Geneva, International Union against Tuberculosis and Lung Disease, 1996.
3. Harries AD et al. Tuberculosis programme changes and treatment outcomes in patients with smear-positive pulmonary tuberculosis in Blantyre, Malawi. Lancet, 1996, 347: 807-809.
4. Kelly GR, Mamon JA, Scott JE. Utility of the health belief model in examining medication compliance among psychiatric outpatients. Social science and medicine, 1987, 25 (11): 1205-1211.
5. Fincham JE, Wertheimer AI. Using the health belief model to predict initial drug therapy defaulting. Social science and medicine, 1985, 20: 101-105.
6. Barnhorn F, Adriaanse H. In search of factors responsible for noncompliance among tuberculosis patients in Wardha district, India. Social science and medicine, 1992, 34 (3): 291-306.
7. Harries AD et al. An audit of HIV testing and HIV serostatus in tuberculosis patients, Blantyre, Malawi. Tuberculosis and lung diseases, 1995, 76: 413-417.
8. Nunn P et al. Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. American review of respiratory diseases, 1992, 146: 849-854.
9. Ackah AN et al. Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire. Lancet, 1995, 345: 607-610.
10. Perriens JH et al. Pulmonary tuberculosis in HIV-infected patients in Zaire: a controlled trial of treatment for either 6 or 12 months. New England journal of medicine, 1995, 332:779-784.
11. Elliott AM et al. The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1995, 89: 78-82.